/Investor DB

Panakes Partners — Full Portfolio

18 tracked investments · listed companies and verified rows first

Alesi Surgicalalesi-surgical.comin𝕏✓ verified

Alesi Surgical develops surgical products by combining product development expertise with commercial knowledge of surgical team needs.

HardwareHealthtechMedical DevicesCardiff, GB

Dominic Griffiths(CEO)in

Co-investorsMercia VenturesIW CapitalIP Group

Corflowcorflow.comin𝕏✓ verified

Corflow develops diagnostic and therapeutic solutions to restore healthy microvascular blood flow in the human body, serving the cardiovascular medical device industry.

HardwareHealthtechMedical Devices

Martin(Physician Co-Founder)Rick Geoffrion(Chairman and CEO)

Co-investors415 CapitalBroadview VenturesLaerdal Million Lives FundKorysMérieux Equity PartnersMonte Carlo Capital+1 more

Allotexallotex.comJul 2023

Boston, US

David Muller(Executive Officer, Director)

Co-investorsSupernova InvestExor Ventures

BetaGlue Therapeuticsbetaglue.comin

BetaGlue develops solutions for the medical device and healthcare sector, supported by a board of directors with expertise in interventional radiology, nuclear medicine, and clinical operations.

BiotechHealthtechMedical DevicesItaly, IT

BoardAlexis Peyroles(Chairman)

Co-investorsLIFTTNeva Sgr.Innogest Capital

Cartheracarthera.euin

Carthera develops SonoCloud®, an implantable ultrasound device that temporarily disrupts the blood-brain barrier to improve drug delivery to the brain for treatment of brain diseases including glioblastoma, brain metastases, and Alzheimer's Disease.

BiotechDeep TechHealthtechMedical DevicesLyon, FR

Alexandre Carpentier(Founder)in

Co-investorsSupernovaAgoranovSupernova InvestUnorthodox Ventures

Complement Therapeuticscomplementtx.comApr 2023

Complement Therapeutics is a clinical-stage biotechnology company developing gene therapies for complement-mediated diseases, with a lead AAV-based candidate (CTx001) for Geographic Atrophy secondary to Age-related Macular Degeneration.

BiotechDigital HealthHealthtechMedical DevicesMunich, DE

Rafiq Hasan(CEO and Managing Director)inMuhammad Ali Memon(Chief Medical Officer)in

Co-investorsBioGeneration VenturesCambridge Innovation CapitalGimvHadean VenturesSeroba Life SciencesBGV+2 more

Deepulldeepull.comin

Deepull develops a multiplex PCR diagnostic system to rapidly identify sepsis-causing pathogens and antibiotic resistance markers directly from blood samples in approximately one hour, targeting hospitals and clinical laboratories.

Medical Devices

Co-investorsAsabys PartnersKurma PartnersAlta Life SciencesColumbus Venture Partners

Ebamedeba-med.com

EBAMed develops non-invasive cardiac ablation technology using particle/proton beam therapy to treat cardiac arrhythmias, with in-house R&D focused on medical devices and cardiac software.

HealthtechMedical Devices

Giovanni Leo(Co-Founder)Douglas Packer(Co-Founder & Key Advisor)Ugo Amaldi(Co-Founder & Key Advisor)Marina Izzo(Chief Executive Officer & Director)inAdriano Garonna(Chief Technology Officer)inOlivier Coquoz(Head of R&D)

Co-investorsCDP Venture CapitalElysia CapitalLIFTTOCCIDENT

Endostartendostart.comin

Endostart develops and manufactures medical devices for gastrointestinal endoscopy, aimed at healthcare sector professionals.

HardwareHealthtechMedical Devices

Co-investorsEUREKA! VentureLIFTTMI.TO Technology

Endovascular Engineeringendovascularengineering.comin

Endovascular Engineering develops clot removal technologies targeting venous thromboembolism.

Medical Devices

Co-investors415 CapitalNorwest Venture PartnersS3 VenturesGilde Healthcare

Enterprise Therapeuticsenterprisetherapeutics.comin𝕏

Enterprise Therapeutics is a drug discovery company developing therapies for respiratory diseases such as cystic fibrosis, asthma, and COPD.

BiotechHealthtechBrighton, GB

John Ford(Co-founder)inMartin Gosling(Founder)in

Co-investorsEpidarex CapitalNovartis Venture FundVersant VenturesForbionIP Group

InnovHeartinnovheart.comJan 2022 · $55M

InnovHeart develops the Saturn Transcatheter Mitral Valve Replacement (TMVR) system, a trans-septal mitral valve bioprosthesis used in interventional cardiology to treat mitral valve disease.

HealthtechMedical Devices

David James Wilson(Chief Executive Officer)

Co-investorsCDP Venture CapitalIndaco Venture Partners

Nouscomnouscom.com

Nouscom is a biotech company whose investors page lists its venture capital backers.

BiotechHealthtech

Riccardo Cortese(Co-Founder)Marina Udier(Chief Executive Officer and Board Director)Elisa Scarselli(Chief Scientific Officer and Co-Founder)Alfredo Nicosia(Co-founder)Antonella Folgori(Co-founder)Stefano Colloca(Co-founder)

Co-investors5AM VenturesAndera PartnersAngelini VenturesRevelation PartnersXGEN VentureBpifrance+7 more

Salvia Bioelectronicssalviabioelectronics.com

Neuromodulation therapy for migraine relief.

Eindhoven, NL

Hubert Martens(Co-founder; Chief Executive Officer)Daniel Schobben(Co-founder; Chief Innovation Officer)Dr. Wim Pollet(Co-founder; Chief Medical Officer)

Co-investorsDolby Family VenturesInkefInnovation IndustriesLevensohn Venture PartnersSHS CapitalThuja Capital

SideKitapproxima.aiin𝕏

Approxima provides AI agents that handle routine software development tasks including scoping work, writing code, validating fixes in isolated environments, and deploying to production, freeing developers to focus on novel work.

AI & Machine LearningDeveloper ToolsEnterprise SoftwareSan Francisco, US

Ethan Pronev(Founder)inAshish Selvaraj(Founder)in

Co-investorsY Combinator

Vivasure Medicalvivasuremedical.comin

Vivasure Medical develops polymer-based vascular closure devices and delivery systems for structural heart and endovascular interventions.

BiotechHealthtechMedical DevicesGalway, IE

Co-investorsFountain Healthcare Partners

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

DISCO PharmaceuticalsRelief

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.